Floatz logo

Autologous Cd34+ Cells Transduced With Tns9.3.55

Beta-Thalassemia Major

Daniel BauerunclassifiedPhase 1/2Active
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

30 Active assets in the Beta-Thalassemia Major cohort.

Asset / SponsorPhaseRating
Deferasirox
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Hydroxyurea
Bahria University
Phase 4BBB
Deferiprone
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Desferrioxamine B
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Tacrolimus
M.D. Anderson Cancer Center
Phase 4BBB

View all 50 →

Same molecule, other indications

Autologous Cd34+ Cells Transduced With Tns9.3.55 is also rated in:

severe combined immunodeficiencyDormant
BB
Indicative · Phase 1/2
64 / 100
View asset →
sickle cell diseaseActive
CCC
Indicative · Phase 2
52 / 100
View asset →
beta thalassemiaActive
CCC
Indicative · Phase 1/2
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →